JP2013530212A - プラミペキソールまたはその薬学的に許容される塩を含む安定性の改善された徐放型薬学組成物 - Google Patents

プラミペキソールまたはその薬学的に許容される塩を含む安定性の改善された徐放型薬学組成物 Download PDF

Info

Publication number
JP2013530212A
JP2013530212A JP2013518223A JP2013518223A JP2013530212A JP 2013530212 A JP2013530212 A JP 2013530212A JP 2013518223 A JP2013518223 A JP 2013518223A JP 2013518223 A JP2013518223 A JP 2013518223A JP 2013530212 A JP2013530212 A JP 2013530212A
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
sustained
pramipexole
release
sustained release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013518223A
Other languages
English (en)
Japanese (ja)
Inventor
イ，サンジュン
チャン，クァンヨン
アン，ジェスン
チョ，ジェミン
カム，ソンフン
Original Assignee
ヒュンダイ ファーム カンパニー リミテッド
バイオ ファーマティス カンパニー リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヒュンダイ ファーム カンパニー リミテッド, バイオ ファーマティス カンパニー リミテッド filed Critical ヒュンダイ ファーム カンパニー リミテッド
Publication of JP2013530212A publication Critical patent/JP2013530212A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2013518223A 2010-07-02 2011-05-12 プラミペキソールまたはその薬学的に許容される塩を含む安定性の改善された徐放型薬学組成物 Pending JP2013530212A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020100064044A KR101307334B1 (ko) 2010-07-02 2010-07-02 프라미펙솔 또는 이의 약학적으로 허용되는 염을 포함하는 안정성이 개선된 서방형 약학 조성물
KR10-2010-0064044 2010-07-02
PCT/KR2011/003515 WO2012002644A2 (fr) 2010-07-02 2011-05-12 Composition pharmaceutique à libération prolongée contenant du pramipexole, ou l'un de ses sels pharmaceutiquement acceptables, présentant une meilleure stabilité

Publications (1)

Publication Number Publication Date
JP2013530212A true JP2013530212A (ja) 2013-07-25

Family

ID=45402507

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013518223A Pending JP2013530212A (ja) 2010-07-02 2011-05-12 プラミペキソールまたはその薬学的に許容される塩を含む安定性の改善された徐放型薬学組成物

Country Status (4)

Country Link
EP (1) EP2588106A4 (fr)
JP (1) JP2013530212A (fr)
KR (1) KR101307334B1 (fr)
WO (1) WO2012002644A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2529984C (fr) 2003-06-26 2012-09-25 Isa Odidi Capsules contenant un inhibiteur de la pompe a protons comprenant des unites secondaires differemment structurees permettant une liberation retardee de l'ingredient actif
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
CN104825397A (zh) 2006-04-03 2015-08-12 伊萨·奥迪迪 含有机溶胶涂层的受控释放递送物件
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
EP2906202A4 (fr) * 2012-10-15 2016-04-27 Isa Odidi Formulations de médicament pour administration par voie orale
CN105456216B (zh) * 2014-08-18 2019-11-05 江苏神龙药业股份有限公司 盐酸普拉克索缓释片剂组合物及其制备方法
CN106474084B (zh) * 2015-08-28 2020-12-11 江苏先声药业有限公司 一种盐酸普拉克索缓释制剂及其制备方法
CN107951853B (zh) * 2016-10-17 2022-04-08 海思科制药(眉山)有限公司 一种盐酸普拉克索缓释药物组合物及其制备方法
CN108785263B (zh) * 2017-04-26 2021-06-29 江苏恒瑞医药股份有限公司 普拉克索或其药用盐的固体药物组合物及其制备方法
CN114939112B (zh) * 2017-12-28 2024-03-01 北京北大维信生物科技有限公司 普拉克索缓释药物组合物、其制备方法及用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005538105A (ja) * 2002-07-25 2005-12-15 ファルマシア・コーポレーション 水不溶性ポリマーおよび水溶性の小孔形成物質からなる２層により被覆された固体剤形の製造方法
WO2007054976A2 (fr) * 2005-11-08 2007-05-18 Panacea Biotec Ltd. Nouvelles compositions pharmaceutiques a liberation controlee a base de lipides
WO2007090882A2 (fr) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Compositions pharmaceutiques

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
EP2431027A1 (fr) * 2004-08-13 2012-03-21 Boehringer Ingelheim International GmbH Formulation de pastille à libération prolongée contenant du pramipexole ou l'un de ses sels pharmaceutiquement acceptable, son procédé de fabrication et utilisation associée
WO2006046256A1 (fr) 2004-10-27 2006-05-04 Alembic Limited Formulation a liberation prolongee de dihydrochlorure de pramipexole
WO2007002518A1 (fr) * 2005-06-23 2007-01-04 Spherics, Inc. Formes de dosage de pramipexole a liberation retardee ou a liberation prolongee/retardee
WO2008068778A2 (fr) 2006-12-05 2008-06-12 Alembic Limited Composition pharmaceutique à libération prolongée de pramipexole
US20090304794A1 (en) * 2008-06-09 2009-12-10 Supernus Pharmaceuticals, Inc. Controlled release formulations of pramipexole
WO2011037976A2 (fr) * 2009-09-22 2011-03-31 Dr. Reddy's Laboratories Limited Formulations pharmaceutiques de pramipexole

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005538105A (ja) * 2002-07-25 2005-12-15 ファルマシア・コーポレーション 水不溶性ポリマーおよび水溶性の小孔形成物質からなる２層により被覆された固体剤形の製造方法
WO2007054976A2 (fr) * 2005-11-08 2007-05-18 Panacea Biotec Ltd. Nouvelles compositions pharmaceutiques a liberation controlee a base de lipides
WO2007090882A2 (fr) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Compositions pharmaceutiques

Also Published As

Publication number Publication date
KR101307334B1 (ko) 2013-09-12
WO2012002644A2 (fr) 2012-01-05
KR20120003278A (ko) 2012-01-10
EP2588106A2 (fr) 2013-05-08
WO2012002644A3 (fr) 2012-04-12
EP2588106A4 (fr) 2014-01-01

Similar Documents

Publication Publication Date Title
JP2013530212A (ja) プラミペキソールまたはその薬学的に許容される塩を含む安定性の改善された徐放型薬学組成物
JP4757872B2 (ja) プラミペキソール又はその医薬品として許容される塩を含む放出が延長された錠剤調合物、その製造方法及びその使用
AU2015204218B2 (en) Pharmaceutical compositions comprising AZD9291
EP2974720B1 (fr) Préparation à libération prolongée de mosapride pour fournir des effets cliniques pharmacologiques avec une administration une fois par jour
JPWO2010038690A1 (ja) 放出制御医薬組成物
TW201501730A (zh) 用於口服投藥之包含非晶型托伐普坦（Ｔｏｌｖａｐｔａｎ）的懸浮液
US9616027B2 (en) Pramipexole sustained release tablet formulation and manufacturing method thereof and use thereof
JP2016188181A (ja) ミラベグロン含有放出制御錠剤
JP2020525541A (ja) 薬剤学的製剤およびその製造方法
CN109875972B (zh) 一种奥美沙坦酯氨氯地平药物组合物
JP2016512845A (ja) ソバプレビル錠剤
JP6680297B2 (ja) 経口投与用医薬組成物
EP2134325A2 (fr) Formes posologiques solides stables d'un antidépresseur
JP2009507875A (ja) ３−（２−ジメチルアミノメチル−シクロヘキシル）−フェノールの徐放性製剤
CN106983729B (zh) 普拉克索缓释片及制备方法
CN106983728B (zh) 普拉克索缓释片及制备方法
US20170209455A1 (en) Solid Pharmaceutical Composition Comprising PI3K-Inhibitor
AU2015287336B2 (en) Pharmaceutical dosage forms
CN109966256B (zh) 一种普拉克索缓释药物组合物、其制备方法及用途
JP5563371B2 (ja) クエチアピンフマル酸塩含有経口用錠剤
EP4260848A1 (fr) Composition pharmaceutique pour forme posologique solide contenant du nilotinib et son procédé de préparation
KR20160082170A (ko) 리바록사반 함유 경구용 고형제제
WO2022138717A1 (fr) Préparation solide orale
TW202216148A (zh) 包含呔嗪酮衍生物之醫藥組合物

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140422

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150331

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150901